Avantor Inc (NYSE:AVTRpA.PFD)
$ 90.81 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 50.60 PB Ratio: 2.79 GF Score: 76/100

Avantor Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 12:00PM GMT
Release Date Price: $105.47 (+1.21%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

I guess we're good to go. Thank you, everybody. It's great to be in person again. Welcome to Barclays Conference. It's my pleasure to speak with Avantor and CFO, Thomas Szlosek.

With that, I guess we can dig right into it.

Questions & Answers

Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

So Tom, plenty of macro, we got to kind of go over that first. So let's go in. I know you have small Ukraine, Russia exposure, but you guys have a pretty sizable European business. So are you starting to see any cracks there? Just give us an idea of how the demand environment played out versus your expectations throughout the quarter.

Thomas A. Szlosek
Avantor, Inc. - Executive VP & CFO

Yes. Yes. Thanks. Thanks, Luke, and good morning, everybody. Just to set things at the outset. From a guidance perspective, for 2022, Avantor had set out with 4% to 6% organic growth, roughly 125 basis points of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot